Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125778831 | 12577883 | 1 | I | 20160303 | 20160721 | 20160721 | PER | GR-LUPIN PHARMACEUTICALS INC.-2016-01026 | LUPIN | KARAOULANIS S, SYNGELAKIS M, FOKAS K, O^DONNELL J. RHABDOMYOLYSIS AFTER LAMOTRIGINE OVERDOSE: A CASE REPORT AND REVIEW OF THE LITERATURE. ANNALS OF GENERAL PSYCHIATRY. 2016;15(6):1-4. | 32.00 | YR | UNK | Y | 0.00000 | 20160718 | OT | GR | GR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125778831 | 12577883 | 1 | PS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | UNKNOWN | 78691 | 4.5 | G | ||||||||
125778831 | 12577883 | 2 | SS | ETHANOL | ALCOHOL | 1 | Unknown | UNKNOWN | 0 | ||||||||||
125778831 | 12577883 | 3 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125778831 | 12577883 | 1 | Epilepsy |
125778831 | 12577883 | 2 | Product used for unknown indication |
125778831 | 12577883 | 3 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125778831 | 12577883 | Ataxia | |
125778831 | 12577883 | Nystagmus | |
125778831 | 12577883 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |